NYU Langone finds new blood cancer treatment

A study by New York City-based NYU Langone Health found a combination of a drug and protein fragment that prevents the growth of blood cancer cells.

The study, presented at the annual meeting of the American Society of Hematology Dec. 9, designed a monobody with a simple protein framework and paired it with a drug called MMAE, which prevents cells from multiplying. The combination stopped abnormal growth in both cell tests and live animals, according to a Dec. 9 system news release.

"Our conjugate improved survival in early tests and has the potential to be important clinically against multiple myeloma," senior author Dafna Bar-Sagi, PhD, senior vice president, vice dean for science, and chief scientific officer at NYU Langone, said in the release.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars